Cell line · CVCL_0633
U-118MG
Cancer cell line, Homo sapiens. Astrocytoma. Cellosaurus records it as contaminated. 49 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Download JSON
Cite this record
ConductScience Library. U-118MG. Cell lines, record CVCL_0633. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0633
On this page
Cell line
As Cellosaurus gives it.
- Name
- U-118MG
- Accession
- CVCL_0633
- RRID
- RRID:CVCL_0633
- Synonyms
- U-118 MG, U-118-MG, U118-MG, U118MG, U118, 118 MG, 118MG
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 47Y
- Category
- Cancer cell line
- Diseases
- Astrocytoma (NCIt C60781); Astrocytoma (ORDO Orphanet_94)
- Derived from
- Brain (in situ)
- Parent
- U-138MG (CVCL_0020)
- Entry created
- 2012-04-04
- Entry updated
- 2025-04-10
Source Cellosaurus
Problems1
| Problem | Cellosaurus's note |
|---|---|
| Contaminated | Shown to be a U-138MG derivative (PubMed=20143388). |
Source Cellosaurus
Papers49
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Early-stage multi-cancer detection through a plasma extracellular vesicle protein signature. | Cell Rep Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Machine learning model on multi-omics data enables risk stratification and identifies molecular heterogeneity and therapeutic targets in glioblastoma. | Mol Cancer | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ZBTB7B inhibits glioma tumorigenicity by upregulating GPR17 and CXCL10. | J Mol Cell Biol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Glioma-Associated Mesenchymal Stromal/Stem Cells Derived Exosomal miR-191 Promotes the Proneural-to-Mesenchymal Transition in Glioblastoma Cells via PTEN/PI3K/AKT Signaling. | Int J Nanomedicine | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Transcriptome-wide analysis of circRNA and RBP profiles and their molecular relevance for GBM. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Oncolytic Viral Therapy for Glioma by Recombinant Sindbis Virus. | Cancers (Basel) | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Identifying the personalized driver gene sets maximally contributing to abnormality of transcriptome phenotype in glioblastoma multiforme individuals. | Mol Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells. | Mol Oncol | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Dysregulated Lipid Synthesis by Oncogenic IDH1 Mutation Is a Targetable Synthetic Lethal Vulnerability. | Cancer Discov | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Selenium Modulates Cancer Cell Response to Pharmacologic Ascorbate. | Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 49
See all 49 papersRelatives8
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Parent | U-138MG | CVCL_0020 | Cell lines | |
| Derived from it | 1181N1 | CVCL_D317 | Has a recorded problem | Cell lines |
| Derived from it | EDITGENE U-118MG-Cas9 | CVCL_F6HE | Cell lines | |
| Derived from it | EDITGENE U-118MG-CopGFP | CVCL_F6HD | Cell lines | |
| Derived from it | EDITGENE U-118MG-FLUC | CVCL_F6F9 | Cell lines | |
| Derived from it | EH-118MG | CVCL_T447 | Has a recorded problem | Cell lines |
| Derived from it | HyCyte U-118MG KO-hBSG | CVCL_D6CY | Cell lines | |
| Derived from it | HyCyte U-118MG KO-hNTN4 | CVCL_F1UL | Cell lines |
Cell banks4
| Cell bank | Catalog number | Status | Source |
|---|---|---|---|
| ATCC | CRL-7712 | Discontinued | Cellosaurus |
| ATCC | HTB-15 | ATCC | |
| CLS | 300362 | CLS | |
| KCB | KCB 2013002YJ | Cellosaurus |
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0633
GET https://conductscience.org/api/cell-lines/v1/CVCL_0633/papers?page=2